Rockefeller Capital Management L.P. Acquires 27,838 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Rockefeller Capital Management L.P. increased its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 17.4% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 188,279 shares of the company’s stock after purchasing an additional 27,838 shares during the quarter. Rockefeller Capital Management L.P.’s holdings in U.S. Physical Therapy were worth $16,702,000 as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. CBIZ Investment Advisory Services LLC boosted its position in shares of U.S. Physical Therapy by 59.8% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company’s stock worth $29,000 after buying an additional 122 shares during the period. Venturi Wealth Management LLC boosted its position in U.S. Physical Therapy by 3,200.0% during the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the company’s stock worth $64,000 after acquiring an additional 704 shares during the last quarter. Pacer Advisors Inc. bought a new position in shares of U.S. Physical Therapy during the 4th quarter worth approximately $113,000. Mutual of America Capital Management LLC acquired a new stake in shares of U.S. Physical Therapy in the fourth quarter valued at approximately $203,000. Finally, KLP Kapitalforvaltning AS acquired a new position in U.S. Physical Therapy during the fourth quarter worth $257,000.

U.S. Physical Therapy Price Performance

NYSE:USPH opened at $69.96 on Tuesday. U.S. Physical Therapy, Inc. has a 12-month low of $62.77 and a 12-month high of $108.14. The firm has a market capitalization of $1.06 billion, a price-to-earnings ratio of 74.43, a P/E/G ratio of 3.54 and a beta of 1.38. The stock’s 50 day moving average price is $77.97 and its two-hundred day moving average price is $85.22. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings data on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing analysts’ consensus estimates of $0.69 by ($0.04). The company had revenue of $180.45 million for the quarter, compared to the consensus estimate of $173.10 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. On average, analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 14th were issued a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.57%. The ex-dividend date of this dividend was Friday, March 14th. This is a boost from U.S. Physical Therapy’s previous quarterly dividend of $0.44. U.S. Physical Therapy’s payout ratio is currently 97.83%.

Insider Activity

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,730 shares of the stock in a transaction on Friday, March 7th. The stock was sold at an average price of $82.11, for a total transaction of $142,050.30. Following the transaction, the chief operating officer now owns 7,168 shares in the company, valued at $588,564.48. This trade represents a 19.44 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.70% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

USPH has been the topic of several recent research reports. Bank of America upgraded shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and lifted their price target for the company from $100.00 to $115.00 in a research note on Monday, December 16th. StockNews.com upgraded U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Wednesday, April 9th. Barrington Research decreased their price target on U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating for the company in a research note on Friday, February 28th. JMP Securities initiated coverage on U.S. Physical Therapy in a research note on Monday, December 16th. They set an “outperform” rating and a $113.00 price objective on the stock. Finally, William Blair reissued a “market perform” rating on shares of U.S. Physical Therapy in a research note on Thursday, February 27th. Two research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, U.S. Physical Therapy currently has an average rating of “Moderate Buy” and an average price target of $109.00.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.